THE HAGUE (AFP) – The European Union’s (EU) medicines watchdog yesterday started a rolling review of Spanish pharmaceutical HIPRA’s coronavirus booster jab, saying early results showed it to be effective against the rampant Omicron strain.
“Preliminary results suggest that the immune response with Covid-19 vaccine HIPRA may be effective against SARS-CoV-2, including variants of concern such as Omicron,” the European Medicines Agency said in a statement.
